Cargando…

Bmal1 Regulates Prostate Growth via Cell-Cycle Modulation

The circadian clock system exists in most organs and regulates diverse physiological processes, including growth. Here, we used a prostate-specific Bmal1-knockout mouse model (pBmal1 KO: PbsnCre+; Bmal1(fx/fx)) and immortalized human prostate cells (RWPE-1 and WPMY-1) to elucidate the role of the pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Masakatsu, Kono, Jin, Sengiku, Atsushi, Nagumo, Yoshiyuki, Mathis, Bryan J., Shimba, Shigeki, Taketo, Makoto Mark, Kobayashi, Takashi, Ogawa, Osamu, Negoro, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569634/
https://www.ncbi.nlm.nih.gov/pubmed/36232573
http://dx.doi.org/10.3390/ijms231911272
Descripción
Sumario:The circadian clock system exists in most organs and regulates diverse physiological processes, including growth. Here, we used a prostate-specific Bmal1-knockout mouse model (pBmal1 KO: PbsnCre+; Bmal1(fx/fx)) and immortalized human prostate cells (RWPE-1 and WPMY-1) to elucidate the role of the peripheral prostate clock on prostate growth. Bmal1 KO resulted in significantly decreased ventral and dorsolateral lobes with less Ki-67-positive epithelial cells than the controls. Next, the cap analysis of gene expression revealed that genes associated with cell cycles were differentially expressed in the pBmal1 KO prostate. Cdkn1a (coding p21) was diurnally expressed in the control mouse prostate, a rhythm which was disturbed in pBmal1 KO. Meanwhile, the knockdown of BMAL1 in epithelial RWPE-1 and stromal WPMY-1 cell lines decreased proliferation. Furthermore, RWPE-1 BMAL1 knockdown increased G0/G1-phase cell numbers but reduced S-phase numbers. These findings indicate that core clock gene Bmal1 is involved in prostate growth via the modulation of the cell cycle and provide a rationale for further research to link the pathogenesis of benign prostatic hyperplasia or cancer with the circadian clock.